Dr Mark Kris discusses the increasing precision of lung cancer therapies and the need for additional testing to find ...

Jonathan Thompson, MD, MS, emphasized that comprehensive biomarker testing with next-generation sequencing and PD-L1 analysis—implemented as reflex testing at biopsy—is essential to guide precision ...

Payer perspective regarding decisions for covering the costs of molecular assays in oncology and reimbursing oncologists for treatments provided to patients while navigating long turnaround times ...

Lymphocyte Infiltration in Breast Cancer: A Key Prognostic Factor That Should Not Be Ignored This study of mutation testing in patients with NSCLC 25 and other studies that are measuring other genetic ...

"Clinicians performing tumor biopsy need to ensure that there’s adequate tissue for both diagnosis and NGS testing. Having immediate pathology review of biopsy specimens in the operating room can ...